BRPI0407193A - formulação aperfeiçoada para agentes de clareamento da pele - Google Patents

formulação aperfeiçoada para agentes de clareamento da pele

Info

Publication number
BRPI0407193A
BRPI0407193A BRPI0407193-0A BRPI0407193A BRPI0407193A BR PI0407193 A BRPI0407193 A BR PI0407193A BR PI0407193 A BRPI0407193 A BR PI0407193A BR PI0407193 A BRPI0407193 A BR PI0407193A
Authority
BR
Brazil
Prior art keywords
skin
skin whitening
whitening agents
improved formulation
lightening agent
Prior art date
Application number
BRPI0407193-0A
Other languages
English (en)
Inventor
Xina Nair
Original Assignee
Warner Lambert Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Warner Lambert Co filed Critical Warner Lambert Co
Publication of BRPI0407193A publication Critical patent/BRPI0407193A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/02—Preparations for care of the skin for chemically bleaching or whitening the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/34—Alcohols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/34—Alcohols
    • A61K8/347—Phenols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/4973—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with oxygen as the only hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/16—Emollients or protectives, e.g. against radiation

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Birds (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Emergency Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Toxicology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Cosmetics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

"FORMULAçãO APERFEIçOADA PARA AGENTES DE CLAREAMENTO DA PELE". A presente invenção refere-se a uma nova formulação tópica para agentes de clareamento da pele, tais como 4-cicioalquilresorcinois. Esta nova formulação acentua a eficácia do agente de clareamento da pele. Isto permite ao médico, ao consumidor, utilizar uma dose mais baixa do agente de clareamento da pele (isto é utilizar uma concentração mais baixa do agente de clareamento da pele). A formulação utiliza um veículo que contém um composto de hidroxila em mistura acrescentada com um co-solvente.
BRPI0407193-0A 2003-02-03 2004-01-22 formulação aperfeiçoada para agentes de clareamento da pele BRPI0407193A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US44449603P 2003-02-03 2003-02-03
PCT/IB2004/000240 WO2004069221A1 (en) 2003-02-03 2004-01-22 Improved formulation for skin-lightening agents

Publications (1)

Publication Number Publication Date
BRPI0407193A true BRPI0407193A (pt) 2006-02-14

Family

ID=32850872

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0407193-0A BRPI0407193A (pt) 2003-02-03 2004-01-22 formulação aperfeiçoada para agentes de clareamento da pele

Country Status (9)

Country Link
US (1) US20060257340A1 (pt)
EP (1) EP1592397B1 (pt)
JP (1) JP2006516605A (pt)
AT (1) ATE462476T1 (pt)
BR (1) BRPI0407193A (pt)
CA (1) CA2513949A1 (pt)
DE (1) DE602004026272D1 (pt)
MX (1) MXPA05008243A (pt)
WO (1) WO2004069221A1 (pt)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060210497A1 (en) * 2005-03-18 2006-09-21 Unilever Home & Personal Care Usa, Division Of Conopco, Inc. Novel resorcinol derivatives
US20060210498A1 (en) * 2005-03-18 2006-09-21 Unilever Home & Personal Care Usa, Division Of Conopco, Inc. Novel resorcinol derivatives for skin
FR2930145B1 (fr) * 2008-04-16 2012-08-03 Fabre Pierre Dermo Cosmetique Utilisation d'un extrait de myrte comme depigmentant.
US8496917B2 (en) * 2009-11-13 2013-07-30 Sytheon Ltd Compositions and methods for improving skin appearance
GB0922200D0 (en) * 2009-12-21 2010-02-03 Xyrex Ltd Composition, use and method of preparation thereof
CN103025311B (zh) * 2010-05-25 2016-03-16 西姆莱斯有限公司 作为皮肤和/或毛发美白活性物的氨基甲酸薄荷酯化合物
US20130011347A1 (en) * 2011-07-07 2013-01-10 Paul Robert Tanner Personal Care Compositions With Improved Solubility of a Solid Cosmetic Active
WO2014138471A2 (en) 2013-03-08 2014-09-12 Ampere Life Sciences, Inc. Resorcinol compounds for dermatological use
FR3045604B1 (fr) * 2015-12-18 2018-01-26 L'oreal Procede de depigmentation des matieres keratiniques a l'aide de composes thiopyridinones

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4711904A (en) * 1986-08-04 1987-12-08 Luzzi Louis A Method of treating skin disorders
ES2114569T3 (es) * 1991-10-16 1998-06-01 Richardson Vicks Inc Sistema mejorado de penetracion en la piel para la administracion topica mejorada de farmacos.
US5833998A (en) * 1995-11-06 1998-11-10 The Procter & Gamble Company Topical compositions for regulating the oily/shiny appearance of skin
US5824326A (en) * 1997-06-27 1998-10-20 Chesebrough-Pond's Usa Co., Division Of Conopco, Inc. Activity enhancement of ferulic acid with dimethyl isosorbride in cosmetic compositions
BR9803596A (pt) * 1997-09-23 2000-04-25 Pfizer Prod Inc Derivados do resorcinol.
US6878381B2 (en) * 1999-03-22 2005-04-12 Pfizer, Inc Resorcinol composition
US6828460B2 (en) * 1999-03-22 2004-12-07 Pfizer Inc. Resorcinol derivatives
US6762158B2 (en) * 1999-07-01 2004-07-13 Johnson & Johnson Consumer Companies, Inc. Personal care compositions comprising liquid ester mixtures
KR101018527B1 (ko) * 2002-09-20 2011-03-03 에프엠씨 코포레이션 미정질 셀룰로즈를 함유하는 화장품 조성물
US9211259B2 (en) * 2002-11-29 2015-12-15 Foamix Pharmaceuticals Ltd. Antibiotic kit and composition and uses thereof

Also Published As

Publication number Publication date
US20060257340A1 (en) 2006-11-16
CA2513949A1 (en) 2004-08-19
WO2004069221A1 (en) 2004-08-19
ATE462476T1 (de) 2010-04-15
EP1592397A1 (en) 2005-11-09
DE602004026272D1 (de) 2010-05-12
JP2006516605A (ja) 2006-07-06
EP1592397B1 (en) 2010-03-31
MXPA05008243A (es) 2005-10-05

Similar Documents

Publication Publication Date Title
TW200744654A (en) Improved oral compositions comprising zinc citrate and/or tocopherol agents
MX2007006539A (es) Sistema para la absorcion percutanea mejorada de los agentes beneficiadores de la piel.
IN2012DN02817A (pt)
AR052057A1 (es) Composiciones orales que contienen extractos de rosmarinus y metodos ralacionados
DE602005001170D1 (de) Kosmetisches Mittel Formulierungskit
HK1093678A1 (en) Cosmetic composition containing nicotinamide and self tanning agent for use as self tanning composition
GT200400126A (es) Compuestos activos antitranspirantes de aluminio/zirconio/glicina, estabilizados con betaina
ATE464055T1 (de) Topische zusammensetzungen mit phosphorylierten polyphenolen
CR8428A (es) Agente endoparasiticidas para la administracion topica
BRPI0408476A (pt) métodos para melhorar a qualidade da pele
WO2006007487A3 (en) Cosmetic compositions and methods containing a tanning agent and liposome-enscapsulated ursolic acid
EP2349279A4 (en) ALDEHYDE DEHYDROGENASE MODULATORS AND METHOD OF USE THEREOF
PL1802376T3 (pl) Transparentna kompozycja kosmetyczna lub dermatologiczna
PT2465493E (pt) Composições tópicas para a prevenção e tratamento da irritação das células mucosas
WO2006055352A3 (en) Methods of treating cancer with lipid-based platinum compound formulations administered intraperitoneally
ATE279910T1 (de) Tensid für äusserlich anzuwendende hautpräparate und diese beinhaltende äusserlich anzuwendende hautpräparate
MX2010005012A (es) Composiciones para el tratamieno y prevencion de inflamacion de los parpados que comprenden un ingrediente osmoticamente activo y un vasocosntrictor.
BRPI0407193A (pt) formulação aperfeiçoada para agentes de clareamento da pele
WO2007056236A3 (en) Methods of treating cancer with lipid-based platinum compound formulations administered intravenously
CY1109507T1 (el) Φαρμακευτικη συνθεση η οποια περιλαμβανει ενα ελαστομερες οργανοπολυσιλοξανιο και μια διαλυτοποιημενη δραστικη ουσια
AR032872A1 (es) Composicion para aclarar la piel y el metodo de aplicacion
AR057648A1 (es) Composicion de metaflumizona para la administracion topica
BRPI0414114A (pt) uso de defibrotide, formulação, e, método para tratar um mamìfero afetado por um tumor
AR034451A1 (es) Microcapsulas para la proteccion frente al mal aliento.
CY1111361T1 (el) Νεα προσδεματα συναγωνιστες των υποδοχεων rar, χρηση στην ανθρωπινη ιατρικη καθως και στην κοσμετολογια

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 8A ANUI DADE.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2129 DE 25/10/2011.

B15K Others concerning applications: alteration of classification

Ipc: A61Q 19/02 (2006.01), A61K 8/34 (2006.01), A61K 8/